Scholarlink

Purpose <p>Tobacco cessation is an important supportive component of cancer care. We developed a novel program to overcome cancer&#xa0;patient barriers to tobacco cessation and improve outcomes.</p> Methods <p>The personal pathways to success (PPS) program consisted of core components of a motivational interview, an instructional video on tobacco cessation, referral to cessation consultation, and/or an offer of cessation medications. Patients who agreed to participate in PPS were also offered the choice of 30 additional PPS supplemental support cessation services. Participants were active smokers before planned surgery at City of Hope (COH) and were referred to the PPS program. We compared tobacco use in patients who participated in PPS with supplemental support services to patients who did not participate. We compared non-Hispanic white patients to patients from minority groups. Evaluations of tobacco use were performed before surgery in all patients, and at 30&#xa0;days, 3, 6, 9, and 12&#xa0;months after surgery in PPS participants, and at 12&#xa0;months in non-participants.</p> Results <p>Among 70 patients, 7 were re-directed by insurance to a non-COH provider. Among the other 63 patients, 58 completed the motivational interview (acceptability rate 92%). Thirty-five of 63 patients (56%) agreed to participate in PPS with supplemental support services. There was equal use of services in non-Hispanic white patients and in patients from minoritized backgrounds. Abstinence preoperatively was 17% in participants and 6% in non-participants. At 12&#xa0;months after surgery, 42% of participants were abstinent versus 17% of non-participants (<i>p</i> = 0.11). At 12&#xa0;months after surgery, 55% of participants were abstinent from combustible tobacco use (abstinent or only vaping) compared to 22% of non-participants (<i>p</i> = 0.037).</p> Conclusions <p>The PPS program is feasible. Participation is associated with reduced cigarette use among cancer patients. Further studies are warranted.</p> Implications <p>Allowing cancer patients to choose among a defined menu of supplemental cessation services offers a method to support patients in their goal of quitting.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Personal pathways to success: an innovative program to overcome cancer patient barriers to tobacco cessation and promote patient participation

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年7月3日

查看全文
  • Cary A. Presant,
  • Brenda Gascon,
  • Sophia Yeung,
  • Jonjon Macalintal,
  • Argelia Sandoval,
  • Dan Raz,
  • Loretta Erhunmwunsee,
  • Janet Cronkhite,
  • Khristie Davy,
  • Mary Cianfrocca,
  • Ravi Salgia,
  • Yuman Fong,
  • Kimlin Tam Ashing

摘要

Purpose

Tobacco cessation is an important supportive component of cancer care. We developed a novel program to overcome cancer patient barriers to tobacco cessation and improve outcomes.

Methods

The personal pathways to success (PPS) program consisted of core components of a motivational interview, an instructional video on tobacco cessation, referral to cessation consultation, and/or an offer of cessation medications. Patients who agreed to participate in PPS were also offered the choice of 30 additional PPS supplemental support cessation services. Participants were active smokers before planned surgery at City of Hope (COH) and were referred to the PPS program. We compared tobacco use in patients who participated in PPS with supplemental support services to patients who did not participate. We compared non-Hispanic white patients to patients from minority groups. Evaluations of tobacco use were performed before surgery in all patients, and at 30 days, 3, 6, 9, and 12 months after surgery in PPS participants, and at 12 months in non-participants.

Results

Among 70 patients, 7 were re-directed by insurance to a non-COH provider. Among the other 63 patients, 58 completed the motivational interview (acceptability rate 92%). Thirty-five of 63 patients (56%) agreed to participate in PPS with supplemental support services. There was equal use of services in non-Hispanic white patients and in patients from minoritized backgrounds. Abstinence preoperatively was 17% in participants and 6% in non-participants. At 12 months after surgery, 42% of participants were abstinent versus 17% of non-participants (p = 0.11). At 12 months after surgery, 55% of participants were abstinent from combustible tobacco use (abstinent or only vaping) compared to 22% of non-participants (p = 0.037).

Conclusions

The PPS program is feasible. Participation is associated with reduced cigarette use among cancer patients. Further studies are warranted.

Implications

Allowing cancer patients to choose among a defined menu of supplemental cessation services offers a method to support patients in their goal of quitting.